These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8090816)
21. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine. Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775 [TBL] [Abstract][Full Text] [Related]
22. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine. Johnson KM Fed Proc; 1983 Jun; 42(9):2579-83. PubMed ID: 6133782 [TBL] [Abstract][Full Text] [Related]
23. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex. Abekawa T; Ito K; Koyama T Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144 [TBL] [Abstract][Full Text] [Related]
24. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006 [TBL] [Abstract][Full Text] [Related]
25. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429 [TBL] [Abstract][Full Text] [Related]
26. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. Sams-Dodd F Neuropsychopharmacology; 1998 Apr; 18(4):293-304. PubMed ID: 9509497 [TBL] [Abstract][Full Text] [Related]
27. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. Bakshi VP; Geyer MA J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384 [TBL] [Abstract][Full Text] [Related]
29. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats. Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403 [TBL] [Abstract][Full Text] [Related]
30. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. Bakshi VP; Swerdlow NR; Geyer MA J Pharmacol Exp Ther; 1994 Nov; 271(2):787-94. PubMed ID: 7965797 [TBL] [Abstract][Full Text] [Related]
31. The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats. Hauber W; Lutz S; Münkle M Neuroscience; 1998 Sep; 86(1):147-57. PubMed ID: 9692750 [TBL] [Abstract][Full Text] [Related]
32. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Simon P; Hémet C; Ramassamy C; Costentin J Eur Neuropsychopharmacol; 1995 Dec; 5(4):509-14. PubMed ID: 8998404 [TBL] [Abstract][Full Text] [Related]
33. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats. Fessler RG; Sturgeon RD; Meltzer HY Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876 [TBL] [Abstract][Full Text] [Related]
34. Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats. Kusljic S; van den Buuse M; Gogos A J Integr Neurosci; 2022 Jan; 21(1):17. PubMed ID: 35164453 [TBL] [Abstract][Full Text] [Related]
35. D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats. Horiguchi M; Hannaway KE; Adelekun AE; Huang M; Jayathilake K; Meltzer HY Behav Brain Res; 2013 Feb; 238():36-43. PubMed ID: 23018127 [TBL] [Abstract][Full Text] [Related]
36. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. Krebs-Thomson K; Lehmann-Masten V; Naiem S; Paulus MP; Geyer MA Eur J Pharmacol; 1998 Feb; 343(2-3):135-43. PubMed ID: 9570460 [TBL] [Abstract][Full Text] [Related]
37. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Terranova JP; Chabot C; Barnouin MC; Perrault G; Depoortere R; Griebel G; Scatton B Psychopharmacology (Berl); 2005 Aug; 181(1):134-44. PubMed ID: 15830220 [TBL] [Abstract][Full Text] [Related]
38. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride. Martin P; Waters N; Waters S; Carlsson A; Carlsson ML Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362 [TBL] [Abstract][Full Text] [Related]
39. D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice. Wang P; Cao T; Chen J; Jiang Y; Wang C; Waddington JL; Zhen X Neuropharmacology; 2019 Oct; 157():107675. PubMed ID: 31233824 [TBL] [Abstract][Full Text] [Related]
40. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]. Svensson TH; Mathé JM; Andersson JL; Nomikos GG; Hildebrand BE; Marcus M J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):11S-18S. PubMed ID: 7730496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]